Discovery of 1,6-Naphthyridin-2(1H)-one Derivatives as Novel, Potent, and Selective FGFR4 Inhibitors for the Treatment of Hepatocellular Carcinoma
Author:
Affiliation:
1. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
2. R & D Center, Nanjing Sanhome Pharmaceutical Co. Ltd., Nanjing 211135, China
Funder
Natural Science Foundation of Jiangsu Province
National Natural Science Foundation of China
Natural Science Foundation of Nanjing University of Chinese Medicine
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c01977
Reference46 articles.
1. Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy
2. AASLD guidelines for the treatment of hepatocellular carcinoma
3. The hepatocellular carcinoma market
4. Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
5. FGFR a promising druggable target in cancer: Molecular biology and new drugs
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy;Liver International;2024-05-03
2. Discovery of novel FGFR4 inhibitors through a build-up fragment strategy;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-04-24
3. Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles;Journal of Medicinal Chemistry;2024-04-11
4. Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of Lymphoma;Journal of Medicinal Chemistry;2024-04-02
5. Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges;European Journal of Medicinal Chemistry;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3